Blood-aqueous Barrier Integrity in Eyes Undergoing Intravitreal Bevacizumab Therapy to Treat Neovascular AMD
NCT03744806 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 48
Last updated 2018-11-16
Summary
The aim of this study is to evaluate the effect of repeated intravitreal bevacizumab injections on blood-aqueous barrier permeability in eyes with neovascular age-related macular degeneration (AMD).
Conditions
- Exudative Age-related Macular Degeneration
Interventions
- DRUG
-
Bevacizumab Injection
Sponsors & Collaborators
-
Medical University of Lublin
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-01-31
- Primary Completion
- 2015-09-30
- Completion
- 2018-08-31
More Related Trials
-
Intravitreal Bevacizumab for Choridal Neovascularization Secondary to Age-Related Macular Degeneration
NCT00556348 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Intravitreal Bevacizumab on Non -Age-Related Macular Degeneration (AMD) Related Choroidal Neovascularization (CNV)
NCT00370786 ·Status: COMPLETED ·Phase: PHASE3
-
Intravitreal Bevacizumab Combined With PDT Versus Bevacizumab to Treat Exudative AMD
NCT00684853 ·Status: UNKNOWN ·Phase: PHASE2
-
Efficacy of Retreatments With Intravitreal Bevacizumab
NCT00406744 ·Status: TERMINATED ·Phase: PHASE3
-
Study of the Long-Term Effect of Frequent Anti-VEGF Dosing on Retinal Function in Patients With Neovascular AMD
NCT00533689 ·Status: UNKNOWN ·Phase: PHASE3
-
Bevacizumab for Neovascular Age-related Macular Degeneration
NCT01306591 ·Status: COMPLETED ·Phase: NA
-
The Effects of Bevacizumab and Ranibizumab on Ocular Pulse Amplitude in Neovascular Age Related Macular Degeneration (AMD)
NCT00640640 ·Status: UNKNOWN ·Phase: NA
-
Intravitreal Brolucizumab in Neovascular Age-related Macular Degeneration With Limited Response to Aflibercept
NCT04287348 ·Status: TERMINATED ·Phase: PHASE4
-
Intravitreal Bevacizumab vs. Bevacizumab Combined With Triamcinolone for Neovascular AMD
NCT00370370 ·Status: UNKNOWN ·Phase: PHASE3
-
Bevacizumab and Photodynamic Therapy in Neovascular Age Related Macular Degeneration
NCT00347399 ·Status: TERMINATED ·Phase: PHASE2
-
Single or Combined Protocols for NV-AMD
NCT03552770 ·Status: COMPLETED ·Phase: PHASE4
-
BEOVU Versus Eylea in the Treatment of Age-related Macular Neovascular Degeneration
NCT04882956 ·Status: UNKNOWN ·Phase: NA
-
Bevacizumab and Retinal Vascular Occlusions
NCT00347711 ·Status: WITHDRAWN ·Phase: PHASE3
-
Pain and Visual Outcome in Intravitreal Bevacizumab Injection
NCT02790775 ·Status: COMPLETED ·Phase: PHASE2
-
Intravitreal Bevasizumab VS Sham Treatment in Acute BRVO: A Randomized Clinical Trial
NCT00370851 ·Status: COMPLETED ·Phase: PHASE3
-
Neovascular Morphology and Persistent Disease Activity Among Patients With NV AMD
NCT02367365 ·Status: COMPLETED
-
Evaluation of Retinal and Vascular Features in Macular Degeneration After Intravitreal Injections of Bevacizumab
NCT04138420 ·Status: COMPLETED
-
Bevacizumab Effect on Blood Velocity
NCT01298440 ·Status: COMPLETED
-
Intravitreal Bevacizumab for Inflammatory Neovascular Membranes
NCT00407121 ·Status: WITHDRAWN ·Phase: PHASE3
-
Systemic Avastin Therapy in Age-Related Macular Degeneration
NCT00531024 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Safety and Tolerability of an Intravenous Infusion of ACZ885 in Patients With Wet Age-Related Macular Degeneration
NCT00503022 ·Status: COMPLETED ·Phase: PHASE1
-
Intravitreal Anti-vascular Endothelial Growth Factor Administration and Its Influence on Vitreomacular Interface- and Retinal Morphology in Eyes With Neovascular Age-related Macular Degeneration
NCT03680326 ·Status: COMPLETED
-
Bevacizumab in Combination With Visudyne Photodynamic Therapy (PDT)
NCT00729846 ·Status: COMPLETED ·Phase: PHASE2
-
Intravitreal Bevacizumab for Proliferative Diabetic Retinopathy
NCT00423059 ·Status: COMPLETED ·Phase: NA
-
Targeted Fluorescence Imaging in AMD
NCT05262244 ·Status: COMPLETED ·Phase: PHASE1